About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Agtr2
angiotensin II receptor, type 2
MGI:87966
102 phenotypes from 3 alleles in 7 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Agtr2tm1a(EUCOMM)Wtsi/Agtr2tm1a(EUCOMM)Wtsi
B6JTyr;B6N-Agtr2tm1a(EUCOMM)Wtsi/Wtsi
decreased body weight J:175295
decreased circulating alanine transaminase level J:175295
decreased circulating LDL cholesterol level J:175295
Agtr2tm1Gsb/Y
FVB.129-Agtr2tm1Gsb
abnormal systemic arterial blood pressure J:103237
abnormal vascular smooth muscle morphology J:103237
abnormal vasculogenesis J:103237
abnormal vasoconstriction J:103237
altered response to myocardial infarction J:103066
dilated heart left ventricle J:103066
increased sensitivity to induced morbidity/mortality J:103066
increased vasoconstriction J:103376
vascular smooth muscle hypertrophy J:103376
Agtr2tm1Gsb/Y
involves: 129S1/Sv * 129X1/SvJ * FVB/N
abnormal fluid intake J:29456
abnormal systemic arterial blood pressure J:29456
hypoactivity J:29456
increased fluid intake J:107851
increased systemic arterial systolic blood pressure J:107851
Agtr2tm1Tin/Y
B6.129P2-Agtr2tm1Tin
abnormal heart left ventricle morphology J:146723
abnormal myocardial fiber morphology J:63751
altered response to myocardial infarction J:146723
cardiac fibrosis J:63751, J:146723
decreased heart left ventricle weight J:146723
decreased response of heart to induced stress J:63751
increased sensitivity to induced morbidity/mortality J:146723
thin interventricular septum J:63751
thin ventricular wall J:63751
Agtr2tm1Tin/Y
involves: 129P2/OlaHsd
abnormal amygdala morphology J:102774
abnormal baroreceptor physiology J:103144
abnormal circulating insulin level J:105210
abnormal circulating leptin level J:105210
abnormal eating behavior J:105210
abnormal epididymal fat pad morphology J:105210
abnormal glucose homeostasis J:105210
abnormal habenula morphology J:102774
abnormal hippocampus CA1 region morphology J:102774
abnormal hippocampus CA2 region morphology J:102774
abnormal hippocampus CA3 region morphology J:102774
abnormal kidney cortex morphology J:48005
abnormal lipid homeostasis J:105210
abnormal piriform cortex morphology J:102774
abnormal respiratory quotient J:105210
abnormal response/metabolism to endogenous compounds J:105210
abnormal systemic arterial blood pressure J:105210
abnormal thalamus morphology J:102774
abnormal triglyceride level J:105210
abnormal urine homeostasis J:60075
abnormal urine sodium level J:60075
decreased angiogenesis J:118914
decreased kidney apoptosis J:48005
decreased renal plasma flow rate J:60075
decreased susceptibility to diet-induced obesity J:105210
decreased susceptibility to weight gain J:105210
decreased white fat cell size J:105210
increased angiogenesis J:118914
increased energy expenditure J:105210
increased insulin sensitivity J:105210
increased mean systemic arterial blood pressure J:103144
increased physiological sensitivity to xenobiotic J:103144
increased renal vascular resistance J:60075
increased systemic arterial blood pressure J:103144
increased white fat cell number J:105210
renal interstitial fibrosis J:48005
Agtr2tm1Tin/Y
involves: 129P2/OlaHsd * C57BL/6
abnormal adrenaline level J:102984
abnormal aldosterone level J:102984
abnormal bone trabecula morphology J:147915
abnormal corticosterone level J:102984
abnormal heart rate J:137944
abnormal kidney development J:52542
abnormal kidney morphology J:52542
abnormal noradrenaline level J:102984
abnormal pancreas morphology J:146326
abnormal renal/urinary system morphology J:52542
abnormal renal/urinary system physiology J:52542
abnormal response/metabolism to endogenous compounds J:137944
abnormal ureter development J:52542
abnormal ureter morphology J:52542
absent kidney J:52542
decreased body temperature J:29457
decreased exploration in new environment J:29457
decreased heart weight J:137944
decreased kidney weight J:137944
decreased pancreas weight J:146326
decreased startle reflex J:29457
double ureter J:52542
ectopic kidney J:52542
hydronephrosis J:52542
hydroureter J:52542
hypoalgesia J:29457
increased bone trabecula number J:147915
increased bone volume J:147915
increased circulating adrenocorticotropin level J:102984
increased circulating corticosterone level J:102984
increased fear-related response J:29457
increased mean systemic arterial blood pressure J:137944
increased physiological sensitivity to xenobiotic J:146326
increased systemic arterial blood pressure J:29457
increased systemic arterial diastolic blood pressure J:29457
increased systemic arterial systolic blood pressure J:29457
increased trabecular bone connectivity density J:147915
increased trabecular bone thickness J:147915
large ureter J:52542
pancreas fibrosis J:146326
pancreatic acinar cell atrophy J:146326
polycystic kidney J:52542
renal hypoplasia J:52542
ureteropelvic junction atresia J:52542
ureteropelvic junction stenosis J:52542
ureterovesical junction obstruction J:52542
Agtr2tm1Tin/Y
SWR.129P2-Agtr2tm1Tin
decreased incidence of tumors by chemical induction J:101726
Agtr2tm1Tin/Agtr2tm1Tin
involves: 129P2/OlaHsd
abnormal urine homeostasis J:60075
abnormal urine sodium level J:60075
decreased renal plasma flow rate J:60075
increased renal vascular resistance J:60075
Agtr2tm1Tin/Agtr2tm1Tin
involves: 129P2/OlaHsd * C57BL/6
abnormal adrenaline level J:102984
abnormal aldosterone level J:102984
abnormal corticosterone level J:102984
abnormal heart rate J:137944
abnormal kidney development J:52542
abnormal kidney morphology J:52542
abnormal noradrenaline level J:102984
abnormal pancreas morphology J:146326
abnormal renal/urinary system morphology J:52542
abnormal renal/urinary system physiology J:52542
abnormal response/metabolism to endogenous compounds J:137944
abnormal ureter development J:52542
absent kidney J:52542
decreased heart weight J:137944
decreased kidney weight J:137944
decreased pancreas weight J:146326
dilated ureter J:52542
double ureter J:52542
ectopic kidney J:52542
hydronephrosis J:52542
hydroureter J:52542
increased circulating adrenocorticotropin level J:102984
increased circulating corticosterone level J:102984
increased mean systemic arterial blood pressure J:137944
increased physiological sensitivity to xenobiotic J:146326
large ureter J:52542
pancreas fibrosis J:146326
pancreatic acinar cell atrophy J:146326
polycystic kidney J:52542
renal hypoplasia J:52542
ureteropelvic junction atresia J:52542
ureteropelvic junction stenosis J:52542
ureterovesical junction obstruction J:52542
vesicoureteral reflux J:52542

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
11/07/2017
MGI 6.11
The Jackson Laboratory